Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's Disease

Skillbäck T, Kornhuber J, Blennow K, Zetterberg H, Lewczuk P (2019)


Publication Type: Journal article

Publication year: 2019

Journal

Book Volume: 69

Pages Range: 551-559

Journal Issue: 2

DOI: 10.3233/JAD-190067

Abstract

Background: To alleviate the interpretation of the core Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarkers, amyloid β 1-42 (Aβ 42), total tau (T-tau), and phosphorylated tau (P-tau), the Erlangen Score (ES) interpretation algorithm has been proposed. Objective: In this study, we aim to assess the predictive properties of the ES algorithm on cognitive and neuroimaging outcomes in mild cognitive impairment (MCI). Methods: All MCI subjects with an available baseline CSF sample from ADNI-1 were included (n=193), and assigned an ES between 0 and 4 based on their baseline CSF biomarker profile. Structural magnetic resonance imaging brain scans and MMSE and ADAS-Cog scores were collected at up to 7 times in follow-up examinations. Results: We observed strong and significant correlations between the ES at baseline and neuroimaging and cognitive results with patients with neurochemically probable AD (ES=4) progressing significantly (p≤0.01) faster than those with a neurochemically improbable AD (ES=0 or 1), and the subjects with neurochemically possible AD (ES=2 or 3) in-between these two groups. Conclusion: This study further demonstrates the utility of the ES algorithm as a as a tool in predicting cognitive and imaging progression in MCI patients.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Skillbäck, T., Kornhuber, J., Blennow, K., Zetterberg, H., & Lewczuk, P. (2019). Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's Disease. Journal of Alzheimer's Disease, 69(2), 551-559. https://dx.doi.org/10.3233/JAD-190067

MLA:

Skillbäck, Tobias, et al. "Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's Disease." Journal of Alzheimer's Disease 69.2 (2019): 551-559.

BibTeX: Download